|
Thu, 02/18/2021 - 07:24 |
Cochlear announces next phase in development of a cochlear implant with drug eluting electrode technology |
Cochlear |
|
Mon, 12/16/2019 - 00:46 |
Gilead Announces Topline Results From Phase 2 ATLAS Study in Patients With Bridging Fibrosis (F3) and Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) |
Gilead Sciences |
|
Tue, 12/10/2019 - 16:06 |
Researchers create accurate model of organ scarring using stem cells in a lab |
UCLA |
|
Wed, 10/30/2019 - 17:38 |
Mayo scientists reverse fibrosis in preclinical studies |
Mayo Clinic |
|
Thu, 02/07/2019 - 01:02 |
Evotec and Galapagos enter into collaboration in the field of fibrosis |
FlandersBio |
|
Wed, 01/23/2019 - 12:46 |
'Infinite hug' mechanism may be key to lung fibrosis: U of T research |
UniversityofToronto |
|
Wed, 11/28/2018 - 16:32 |
Fatty Liver Disease and the Link to Liver Cancer |
Roswell Park Ca... |
|
Thu, 11/22/2018 - 22:05 |
Healthy Holidays: Mindfulness, Family History and Leftovers |
Cone Health |
|
Mon, 11/19/2018 - 14:08 |
Biodesign symposium hosts researchers from West China |
Biodesign Institute |
|
Fri, 11/09/2018 - 06:34 |
HemoShears REVEAL-TxTM Platform Identifies Promising New Treatment |
VABIO |
|
Mon, 10/29/2018 - 04:17 |
Novartis announces clinical collaboration with Pfizer to advance the treatment of NASH |
Novartis |
|
Wed, 10/10/2018 - 16:52 |
Teva Presents 25-year Safety Data from Longest Continuous Trial of COPAXONE (glatiramer acetate injection) for the Treatment of Relapsing Forms of Multiple Sclerosis |
Teva Pharmaceutical |
|
Mon, 10/08/2018 - 04:03 |
Rice pursues endgame for diabetes |
RiceUniv |
|
Mon, 10/08/2018 - 02:23 |
Rice U. pursues endgame for diabetes |
RiceUniv |
|
Sun, 10/07/2018 - 20:47 |
Teva to Present New Data at 34th European Committee for Treatment and Research in Multiple Sclerosis Congress in Berlin |
Teva Pharmaceutical |
|
Thu, 10/04/2018 - 17:41 |
Stem Cells Could Be the Key to Treating Severe Blistering Disease, RDEB |
New York Medica... |
|
Thu, 09/27/2018 - 01:52 |
Pathomechanisms deciphered for the two most common age-related eye disorders |
HelsinkiUniv |
|
Sun, 09/16/2018 - 20:34 |
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate |
United Therapeutics |
|
Tue, 08/14/2018 - 08:02 |
E-cigarette vapour disables key immune cells in the lung and boosts inflammation |
University of B... |
|
Fri, 08/10/2018 - 04:13 |
Prometic announces the publication of PBI-4050s antifibrotic activity in liver diseases in journal of pharmacology and... |
Liminal BioSciences |
|
Wed, 07/18/2018 - 10:32 |
ACSH Explains: What's The Story On Asbestos? |
American Counci... |
|
Wed, 06/27/2018 - 18:44 |
Feds back study of congenital heart disease |
RiceUniv |
|
Tue, 05/08/2018 - 20:46 |
Blavatnik Family Foundation gives $15 million to expand fund for innovation in the life sciences at Yale University |
YaleUniversity |
|
Mon, 05/07/2018 - 09:13 |
The Philadelphia Foundation Announces 2018 Brody Fellow |
Philadelphia Fo... |
|
Thu, 05/03/2018 - 15:06 |
Gut check: metabolites shed by intestinal microbiota keep inflammation at bay |
TuftsNow |
